Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
5
×
life sciences
national blog main
amgen
boston blog main
inclisiran
new york blog main
new york top stories
regeneron pharmaceuticals
alirocumab
boston top stories
cholesterol
clinical trials
detroit blog main
detroit top stories
evolocumab
medicines co.
national top stories
pcsk9
alnylam pharmaceuticals
boulder/denver blog main
boulder/denver top stories
evercore isi
fda
heart attack
indiana blog main
indiana top stories
medco
national
new york
pcsk9 inhibitors
praluent
raleigh-durham blog main
raleigh-durham top stories
repatha
rna interference
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
What
cholesterol
5
×
drug
lowering
medicines
new
fda
medco
wave
abbvie’s
acquire
agreed
alnylam
approved
barbecuing
based
billion
bio
brings
camping
cardiologist
cash
center
check
combo
company
compound
conference
data
day
deal
drugs
esperion
esperion’s
evidence
expensive
faces
financial
flop
foe
healthcare
Language
unset
Current search:
cholesterol
×
biotech
×
@xconomy.com
4 years ago
Esperion’s Combo Pill for Lowering Cholesterol Levels Wins FDA Nod
@xconomy.com
4 years ago
Novartis to Acquire MedCo and FDA-Ready Cholesterol Drug for $9.7B
@xconomy.com
4 years ago
Bio Roundup: Cholesterol Check, J&J’s Opioid Hit, AbbVie’s Flop & More
@xconomy.com
4 years ago
New PCSK9 Cholesterol Drug Faces Tough Foe. (Hint: Not Cholesterol.)
@xconomy.com
4 years ago
MedCo Touts New Data for Long-Lasting Heart Drug as Reckoning Looms